A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of Allovectin-7® versus Dacarbazine (DTIC)or Temozolomide
(TMZ) in subjects with recurrent stage 3 or stage 4 melanoma.